SignalPoint Asset Management LLC Acquires 9,390 Shares of Clover Health Investments, Corp. (NASDAQ:CLOV)

SignalPoint Asset Management LLC grew its holdings in Clover Health Investments, Corp. (NASDAQ:CLOV) by 6.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 160,074 shares of the company’s stock after buying an additional 9,390 shares during the quarter. SignalPoint Asset Management LLC’s holdings in Clover Health Investments were worth $504,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of CLOV. Concurrent Investment Advisors LLC bought a new stake in shares of Clover Health Investments in the third quarter valued at approximately $28,000. Sigma Planning Corp purchased a new position in Clover Health Investments during the third quarter valued at approximately $29,000. Parallax Volatility Advisers L.P. purchased a new position in Clover Health Investments during the third quarter valued at approximately $38,000. Vanguard Personalized Indexing Management LLC grew its stake in Clover Health Investments by 54.4% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company’s stock valued at $42,000 after acquiring an additional 12,104 shares in the last quarter. Finally, Realta Investment Advisors purchased a new position in Clover Health Investments during the third quarter valued at approximately $44,000. Institutional investors own 19.77% of the company’s stock.

Clover Health Investments Price Performance

CLOV stock opened at $3.98 on Thursday. Clover Health Investments, Corp. has a one year low of $0.61 and a one year high of $4.71. The firm has a 50 day simple moving average of $3.34 and a two-hundred day simple moving average of $2.96.

Clover Health Investments (NASDAQ:CLOV) last released its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. The business had revenue of $330.99 million during the quarter, compared to analysts’ expectations of $347.60 million. During the same quarter in the previous year, the company earned ($0.09) EPS. As a group, sell-side analysts expect that Clover Health Investments, Corp. will post -0.12 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Craig Hallum assumed coverage on shares of Clover Health Investments in a research note on Tuesday, December 17th. They set a “buy” rating and a $6.00 price objective for the company. UBS Group assumed coverage on shares of Clover Health Investments in a research note on Monday, October 7th. They set a “neutral” rating and a $4.00 price objective for the company.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.